71 results
Page 2 of 4
6-K/A
EX-99.2
5ycmvdkrw0yeh4b
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
3hv s2vjrua
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
ozucyey4
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
46qou
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-1.1
01al1 xhb2v
5 Mar 21
Current report (foreign)
8:15am
424B5
qkd3s
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-5.2
8vwoeif7js 5u8sa
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-1.1
lz2ocx0l05e giv
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
424B5
1zassg7ehus8zx5b
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.2
wise7tzgo
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.2
nvoyqz aey5i9y1k
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.1
tcjybxr4mwi
6 Apr 20
ObsEva SA Announces New Interim Chief Financial Officer
4:00pm
6-K
EX-99.2
u255 e17cy
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
F-3
EX-4.6
3cjytf7wzhys ze
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
486f4kk3zbfec
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-5.2
w7lxm9jsz0qx08ou2f3
7 Aug 19
Shelf registration (foreign)
8:24am